Li, Weihua
Guo, Lei
Tang, Wanxiangfu
Ma, Yutong
Wang, Xiaonan
Shao, Yang
Zhao, Hong
Ying, Jianming http://orcid.org/0000-0002-7301-4118
Funding for this research was provided by:
National Natural Science Foundation of China (81702436)
Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2019PT310026)
CAMS Innovation Fund for Medical Sciences (2017-I2M-1-006)
National Key Research and Development Program (2017YFC1311005)
Article History
Received: 9 February 2021
Accepted: 31 May 2021
First Online: 9 June 2021
Declarations
:
: All study protocols were approved by the ethics committee of the National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, and in accordance with international standards of good clinical practice. Written informed consents were provided by all patients.
: The content of this manuscript has not been previously published and is not under consideration for publication elsewhere.
: Wanxiangfu Tang, Yutong Ma, Xiaonan Wang, and Yang Shao are employees of Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, China. The remaining authors have nothing to declare.